Facilitating Both Evidence and Access: Improving FDA's Accelerated Approval and Expanded Access Pathways

RT @HollyLynchez: My take on this bill w/ @ABatemanHouse (bill remains largely unchanged from several years ago): https://t.co/UMqo75FDSj…

RT @HollyLynchez: My take on this bill w/ @ABatemanHouse (bill remains largely unchanged from several years ago): https://t.co/UMqo75FDSj…

My take on this bill w/ @ABatemanHouse (bill remains largely unchanged from several years ago): https://t.co/UMqo75FDSj Key change since: @US_FDA has shown itself even more willing to exercise reg flexibility in drug approvals w/o any leg change, cf Relyv

@neumanmd @SenGillibrand I wrote about this bill (prior version) with @ABatemanHouse a while ago. https://t.co/QakNVxnY4Y

@AlMusella https://t.co/3XsEebiUlt

Here's a paper with @ABatemanHouse outlining some of these concerns: https://t.co/X2Xkn9loAa

RT @reshmagar: Experts such as @HollyLynchez & @ABatemanHouse have written on how these programs could be improved including through legisl…

Experts such as @HollyLynchez & @ABatemanHouse have written on how these programs could be improved including through legislation that @EnergyCommerce could (& should) consider to remove barriers for patients hoping to seek access to investigationa

RT @HollyLynchez: My views (with @ABatemanHouse) on Promising Pathways: https://t.co/QakNVxnY4Y

RT @HollyLynchez: My views (with @ABatemanHouse) on Promising Pathways: https://t.co/QakNVxnY4Y

My views (with @ABatemanHouse) on Promising Pathways: https://t.co/QakNVxnY4Y

@factcheckals @SleightFHand @jsross119 @gregggonsalves @cmorten2 @reshmagar More here: https://t.co/QakNVxnY4Y (let me know if you need a PDF)

Facilitating Both Evidence and Access: Improving @US_FDA 's Accelerated Approval and Expanded Access Pathways https://t.co/VlThNyxQko via @ABatemanHouse

RT @walidgellad: Very nice piece on challenges for Accelerated Approval of drugs at FDA, from @HollyLynchez and @ABatemanHouse. Addresses…

RT @walidgellad: Very nice piece on challenges for Accelerated Approval of drugs at FDA, from @HollyLynchez and @ABatemanHouse. Addresses…

RT @walidgellad: Very nice piece on challenges for Accelerated Approval of drugs at FDA, from @HollyLynchez and @ABatemanHouse. Addresses…

RT @JLME_ASLME: The latest @JLME_ASLME is now available, featuring the timely "Facilitating Both Evidence and Access: Improving FDA's Accel…

RT @RandiMHernandez: For more about FDA's #expandedaccess, see this piece by @HollyLynchez and @ABatemanHouse, published online yesterday (…

RT @JLME_ASLME: The latest @JLME_ASLME is now available, featuring the timely "Facilitating Both Evidence and Access: Improving FDA's Accel…

RT @HollyLynchez: Thanks, @ehutch01, for the infinite patience you displayed in letting us edit this till the very last minute to make sure…

RT @JLME_ASLME: The latest @JLME_ASLME is now available, featuring the timely "Facilitating Both Evidence and Access: Improving FDA's Accel…

Thanks, @ehutch01, for the infinite patience you displayed in letting us edit this till the very last minute to make sure the paper was as up-to-date as possible in light of new legislative developments!

RT @JLME_ASLME: The latest @JLME_ASLME is now available, featuring the timely "Facilitating Both Evidence and Access: Improving FDA's Accel…

RT @JLME_ASLME: The latest @JLME_ASLME is now available, featuring the timely "Facilitating Both Evidence and Access: Improving FDA's Accel…

RT @JLME_ASLME: The latest @JLME_ASLME is now available, featuring the timely "Facilitating Both Evidence and Access: Improving FDA's Accel…

The latest @JLME_ASLME is now available, featuring the timely "Facilitating Both Evidence and Access: Improving FDA's Accelerated Approval & Expanded Access Pathways," by @HollyLynchez & @ABatemanHouse. Please take a look! @ASLMENews @PennMEHP @nyu